Lidoderm Buyers, End Payors Win Cert. In Pay-For-Delay MDL
Purchasers of the Lidoderm pain patch won class certification in an antitrust multidistrict litigation against Endo Pharmaceuticals and others on Tuesday when a California federal judge found that both direct purchasers...To view the full article, register now.
Already a subscriber? Click here to view full article